05.15.24 -- A Good Feeling ($$) About Contract Manufacturing

Outsourced Pharma Capacity Update covers the entire pharmaceutical product formulation, manufacturing, and packaging spectrum, emphasizing process development and GMP compliance. Explore innovative solutions from CDMOs with capacity during our new PARTNER WEEK for solid orals, liquid orals, semi-solid, and specialty dosage forms. Register today for the Small Molecule Finished Dosage Form session happening May 22nd.

Achieving bioequivalence for complex generics is an intricate task. This article describes an approach using in vitro–in vivo correlation, PBMK modeling, and more.

Explore the advantages of intranasal drug delivery, including its potential to rapidly treat conditions like migraines and headaches, and deliver medications directly to the brain.

Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.

See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.

Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.